Navigation Links
The birth of biotech: San Francisco, Boston, Geneva or Chicago?

CHICAGO To start off our day, heres a pop biotech quiz to see if you know your biotech history and trivia:
  1. What were the first six biotech companies?
  2. How many of these companies still exist?
  3. How many of them are still completely independent?

While Im willing to bet that most of you will get at least three of the six companies right in the first question, ......

Full article >>> "">Wyeth.

Cetus, originally located in San Francisco and founded in the late 1970s as an innovative cancer therapy company, was acquired by Chiron in the early 1990s.

Amgen, which was originally known as Applied Molecular Genetics, was founded......

Full article >>> st monoclonal antibodies are produced.
  • 1977: The first expression of a human gene in bacteria.
  • 1978: Recombinant insulin is first produced.
  • 1979: Human growth hormone is first synthesized.
  • Also in the 1970s: RNA splicing, gene targeting, discovery of polymerases and of course the first commercial companies to develop genetically engineered products.
    During ......

    Full article >>> sity of Chicago.

    Goldwasser was born in 1922 (hes 82 today) in Brooklyn. After his family moved to Kansas City, he won a scholarship to University of Chicago and majored in biological sciences. During his initial time there, Goldwasser worked in the universitys toxicity lab on antidotes for chemical warfare agents (this was after the Japanese attack on Pearl Harbor).

    Upon graduat......

    Full article >>> o three dialysis patients with his small supply of EPO.

    His goal was to demonstrate an effect on patients with anemia of chronic renal disease. He also advised the University of Chicago and the government that he had a patentable invention. When he didnt hear back from these groups, he forgot about patenting his discovery.

    The results of his small Phase I were promising but incon......

    Full article >>> years later for $250 million). This helped the new company attract west coast VCs, which put up another $12 million. With this investment, the new company was off and running.

    Once funded, EPO became one of the lead projects and Salser invited Goldwasser to join the new Amgens scientific advisory board. Goldwasser preferred to work for Amgen as a consultant and Goldwasser provided Amgen ......

    Full article >>> wasser continued to investigate other aspects of EPO and focused on the kidney cells that produce EPO. While Amgen continued to support his lab at the rate of about $30,000 per year, the NIH lost interest in his work.

    As Goldwasser never patented any of his work, his financial share of Amgens successful sales of EPO never materialized.

    Still, he clearly was the pivotal person in ......

    Full article >>>

  • By Michael Rosen 08/25/04

    Related biology technology :

    1. The state of global biotech: An Ernst & Young perspective
    2. Health-care eyes focus on San Francisco, war of the stents
    3. Historic observatory becomes hot property on Lake Geneva
    Post Your Comments:

    (Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
    (Date:11/24/2015)... Mass. (PRWEB) , ... November 24, 2015 , ... ... to maintain healthy metabolism. But unless it is bound to proteins, copper is ... of Health (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic ...
    (Date:11/24/2015)... - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the "Company"), ... Toronto Stock Exchange, confirms that as of the date ... that would cause the recent movements in the Company,s ... About Aeterna Zentaris Inc. . ... Zentaris is a specialty biopharmaceutical company engaged in developing ...
    (Date:11/24/2015)... 24, 2015 --> ... report "Oligonucleotide Synthesis Market by Product & Services (Primer, ... Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic ... the market is expected to reach USD 1,918.6 Million ... a CAGR of 10.1% during the forecast period. ...
    Breaking Biology Technology:
    (Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
    (Date:10/29/2015)... BOSTON , Oct. 29, 2015  Connected health ... phenomena driving the explosion of technology-enabled health and wellness, ... his new book, The Internet of Healthy ... apps, sensors or smartphones even existed, Dr. Kvedar, vice ... model of health care delivery, moving care from the ...
    (Date:10/27/2015)... , Oct. 27, 2015 Synaptics Inc. (NASDAQ: ... today announced that Google has adopted the Synaptics ® ... controller solutions to power its newest flagship smartphones, the ... Huawei. --> --> ... Google to provide strategic collaboration in the joint development ...
    Breaking Biology News(10 mins):